Beneficial effect of dehydroepiandrosterone on pulmonary hypertension in a rodent model of pulmonary hypertension in infants

Pediatric Research

Volumn 74, Issue 2, 2013, Pages 163-169

  Dumas De La Roque, Eric ^a,b,c   Quignard, Jean François ^a,b   Ducret, Thomas ^a,b   Dahan, Diana ^a,b   Courtois, Arnaud ^a,b   Begueret, Hugues ^a,c   Marthan, Roger ^a,b,c   Savineau, Jean Pierre ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CENTRE DE RECHERCHE CARDIO THORACIQUE DE BORDEAUX   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; POTASSIUM CHLORIDE; PRASTERONE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ECHOGRAPHY; HEART CATHETERIZATION; HEART RIGHT VENTRICLE HYPERTROPHY; HYPOBARISM; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; MUSCLE CONTRACTION; NONHUMAN; PATCH CLAMP; PH; PRIORITY JOURNAL; PULMONARY ARTERY SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION; RAT; SMOOTH MUSCLE FIBER;

EID: 84881246885     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.73     Document Type: Article

References (40)

1. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997;336: 111-7.
2. Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:Suppl 12:13S-24S.
3. Mandegar M, Fung YC, Huang W, Remillard CV, Rubin LJ, Yuan JX. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc Res 2004;68:75-103.
4. Haworth SG. Pulmonary hypertension in the young. Heart 2002;88: 658-64.
5. Haworth SG, Beghetti M. Assessment of endpoints in the pediatric population: congenital heart disease and idiopathic pulmonary arterial hypertension. Curr Opin Pulm Med 2010;16:Suppl 1:S35-41.
6. Archer SL, Weir EK, Wilkins MR. Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation 2010;121:2045-66.
7. Baulieu EE, Corpechot C, Dray F, et al. An adrenal-secreted "androgen": dehydroisoandrosterone sulfate. Its metabolism and a tentative generalization on the metabolism of other steroid conjugates in man. Recent Prog Horm Res 1965;21:411-500.
8. Migeon CJ, Keller AR, Lawrence B, Shepard TH 2nd. Dehydroepiandrosterone and androsterone levels in human plasma: effect of age and sex; dayto-day and diurnal variations. J Clin Endocrinol Metab 1957;17:1051-62.
9. Bonnet S, Dumas-de-La-Roque E, B?ueret H, et al. Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension. Proc Natl Acad Sci USA 2003;100:9488-93.
10. Hampl V, Bov J, Povsilov, V, Herget J. Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats. Eur Respir J 2003;21:862-5.
11. Homma N, Nagaoka T, Karoor V, et al. Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone. Am J Physiol Lung Cell Mol Physiol 2008;295:L71-8.
12. Ducret T, Guibert C, Marthan R, Savineau JP. Serotonin-induced activation of TRPV4-like current in rat intrapulmonary arterial smooth muscle cells. Cell Calcium 2008;43:315-23.
13. Eddahibi S, Fabre V, Boni C, et al. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res 1999;84:329-36.
14. Rodat-Despoix L, Crevel H, Marthan R, Savineau JP, Guibert C. Heterogeneity in 5-HT-induced contractile and proliferative responses in rat pulmonary arterial bed. J Vasc Res 2008;45:181-92.
15. Casteels R, Kitamura K, Kuriyama H, Suzuki H. Excitation-contraction coupling in the smooth muscle cells of the rabbit main pulmonary artery. J Physiol (Lond) 1977;271:63-79.
16. Yuan XJ. Voltage-gated K+ currents regulate resting membrane potential and [Ca2+]i in pulmonary arterial myocytes. Circ Res 1995;77:370-8.
17. Galvez A, Gimenez-Gallego G, Reuben JP, et al. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem 1990;265:11083-90.
18. Zoetis T, Hurtt ME. Species comparison of lung development. Birth Defects Res B Dev Reprod Toxicol 2003;68:121-4.
19. Xu EZ, Kantores C, Ivanovska J, et al. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension. Am J Physiol Heart Circ Physiol 2010;299:H1854-64.
20. Ziino AJ, Ivanovska J, Belcastro R, et al. Effects of rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia. Pediatr Res 2010;67:177-82.
21. Dumas de La Roque E, Bellance N, Rossignol R, et al. DHEA reverses chronic hypoxia/reoxygenation-induced right ventricular dysfunction in rats. Eur Respir J 2012;40:1420-9.
22. Jeffery TK, Wanstall JC. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 2001;92:1-20.
23. Morrell NW, Adnot S, Archer SL, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54:Suppl 1:S20-31.
24. Guilluy C, Eddahibi S, Agard C, et al. RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling. Am J Respir Crit Care Med 2009;179:1151-8.
25. Mair KM, MacLean MR, Morecroft I, Dempsie Y, Palmer TM. Novel interactions between the 5-HT transporter, 5-HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts. Br J Pharmacol 2008;155:606-16.
26. Tuder RM, Chacon M, Alger L, et al. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol 2001;195:367-74.
27. Dessouroux A, Akwa Y, Baulieu EE. DHEA decreases HIF-1alpha accumulation under hypoxia in human pulmonary artery cells: potential role in the treatment of pulmonary arterial hypertension. J Steroid Biochem Mol Biol 2008;109:81-9.
28. Bonnet S, Belus A, Hyvelin JM, Roux E, Marthan R, Savineau JP. Effect of chronic hypoxia on agonist-induced tone and calcium signaling in rat pulmonary artery. Am J Physiol Lung Cell Mol Physiol 2001;281:L193-201.
29. Bonnet S, Hyvelin JM, Bonnet P, Marthan R, Savineau JP. Chronic hypoxiainduced spontaneous and rhythmic contractions in the rat main pulmonary artery. Am J Physiol Lung Cell Mol Physiol 2001;281:L183-92.
30. Peng W, Hoidal JR, Karwande SV, Farrukh IS. Effect of chronic hypoxia on K+ channels: regulation in human pulmonary vascular smooth muscle cells. Am J Physiol 1997;272(4 Pt 1):C1271-8.
31. Chevalier M, Gilbert G, Lory P, Marthan R, Quignard JF, Savineau JP. Dehydroepiandrosterone (DHEA) inhibits voltage-gated T-type calcium channels. Biochem Pharmacol 2012;83:1530-9.
32. Williams MR, Dawood T, Ling S, et al. Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. J Clin Endocrinol Metab 2004;89:4708-15.
33. Bonnet S, Paulin R, Sutendra G, et al. Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis. Circulation 2009;120:1231-40.
34. Dumas de La Roque E, Savineau JP, Metivier AC, et al. Dehydroepiandrosterone (DHEA) improves pulmonary hypertension in chronic obstructive pulmonary disease (COPD): a pilot study. Ann Endocrinol (Paris) 2012 73:20-5.
35. Bonnet S, Dubuis E, Vandier C, Martin S, Marthan R, Savineau JP. Reversal of chronic hypoxia-induced alterations in pulmonary artery smooth muscle electromechanical coupling upon air breathing. Cardiovasc Res 2002;53:1019-28.
36. Bonnet P, Bonnet S, Boissi?e J, et al. Chronic hypoxia induces nonreversible right ventricle dysfunction and dysplasia in rats. Am J Physiol Heart Circ Physiol 2004;287:H1023-8.
37. Agard C, Rolli-Derkinderen M, Dumas-de-La-Roque E, et al. Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension. Br J Pharmacol 2009;158:1285-94.
38. Ducret T, El Arrouchi J, Courtois A, Quignard JF, Marthan R, Savineau JP. Stretch-activated channels in pulmonary arterial smooth muscle cells from normoxic and chronically hypoxic rats. Cell Calcium 2010;48:251-9.
39. Guibert C, Marthan R, Savineau JP. Angiotensin II-induced Ca(2+)-oscillations in vascular myocytes from the rat pulmonary artery. Am J Physiol 1996;270(4 Pt 1):L637-42.
40. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patchclamp techniques for high-resolution current recording from cells and cellfree membrane patches. Pflugers Arch 1981;391:85-100.